Saturday, September 26, 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/n8484d/cns_drug_news) has announced the addition of the "CNS Drug News Issue" newsletter to their offering. Generic competition for the 20mg version of Teva Pharmaceutical Industries current multiple sclerosis market leader Copaxone will be available in the US by September. About Altace (Ramipril) with no Rx This, coupled with growing sales of Biogen s Tecfidera, will see Tecfidera 2015 sales overtake those of Copaxone. These days we all suffer from information overload; by focusing specifically on CNS drugs, the CNS Drug News online service will deliver the information you need in a timely, flexible and convenient format. An ageing population and ever better rates of diagnosis is seeing the incidence of major CNS sectors rise considerably - particularly demanding are the neurodegenerative conditions. Buy Xylocaine (Lidocaine) with free Rx Even so, levels of unmet clinical need remain high and growth is expected to continue. For pharmaceutical company executives, researchers and commercial managers, staying in touch with the latest twists and turns is another matter. Buy Levitra Pack-90 () without Rx That is why CNS Drug News is essential. The CNS Drug News service provides unbeatable coverage: - The full text daily of the latest news reported on all types of CNS drugs for leading CNS conditions - An easy-to-use interface that immediately takes you to the most recently-updated information - An extensive archive of articles, which makes the service a valuable tracking and research tool - A fast and effective search facility allowing you to identify information relevant to you - Daily or weekly email alerts that will ensure you know when new information is added - An RSS feed facility Every day, the researchers and editors - Track the companies and research organisations that are shaping the industry - Monitor results from major conferences and meetings Report the latest developments in current and up-coming CNS drugs, including those for: - Neurodegenerative Disorders - Sleep Disorders - Depression - Psychotic Disorders - Analgesia/Anaesthetics - Epilepsy - Substance Dependence Therapies - Nausea & Vertigo - Cerebrovascular Disorders - Eating Disorders Key Topics Covered: 1. About Flutinap with no Rx Tecfidera Will Be Leading MS Drug In 2015 2. Buy Imodium (Loperamide) with free prescription Neurodegenerative Disorders 3. Buy Cough online Parkinson s Disease - R&D 4. http://cholesterolreviews.wordpress.com Biotie Provides Update On Tozadenant Phase III Programme 5. R&D 6. R&D 7. GW Receives FDA ODD For CBD For NHIE 8. R&D 9. Follow-Up Announcement Made On Preliminary Findings From Lurasidone Phase III Study 10. Product Updates 11. R&D 12. Product Updates For more information visit .researchandmarkets.com/research/n8484d/cns_drug_news About Research and Markets Research and Markets is the world s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Friday, September 11, 2015

Crohn's Disease - Pipeline Review, H1 2015

. http://asthmareview.wordpress.com DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/l6pzmr/crohns_disease) has announced the addition of the "Crohn s Disease - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Crohn s Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. About Zyprexa (Olanzapine) without prescription It also reviews key players involved in the therapeutic development for Crohn s Disease and special features on late-stage and discontinued projects. the report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Buy Avodart (Dutasteride) with no Rx The report is built using data and information sourced from the proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the team. Buy Aceon (Perindopril) without Rx Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Femodene with free Rx Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. About Malegra FXT (Sildenafil/Fluoxetine) It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Mentioned Partial list of the 70+ companies mentioned in this comprehensive report: 4SC AB Science Baliopharm BIOCAD Calypso Biotech Celgene Daiichi Sankyo DBV Technologies Effimune Eisai Farmacija d.o.o. Buy Cell Volumizers online Tuzla Ferring International Center Galapagos Genentech iCo Therapeutics Idera Pharmaceuticals Johnson & Johnson Kyorin Pharmaceutical Mabion Mesoblast Neovacs Oncobiologics Oncodesign Pfenex Pfizer Qu Biologics Receptos Sandoz International Selexys Pharmaceuticals Takeda Pharmaceutical Company Teva Pharmaceutical Industries Virobay Winston Pharmaceuticals For more information visit .researchandmarkets.com/research/l6pzmr/crohns_disease

Wednesday, September 2, 2015

. Buy Bronchial online Buy Naprosyn (Naproxen) without Rx DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/jnsg6k/acute_heart) has announced the addition of the "Acute Heart Failure - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Acute Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. http://doctor-answers.blogspot.com/ About Eumosone Viagra Soft (Sildenafil Citrate) It also reviews key players involved in the therapeutic development for Acute Heart Failure and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Nimotop (Nimodipine) with free prescription Buy Chloromycetin (Chloramphenicol) with no Rx It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development Amgen Inc. Angion Biomedica Corp. Bayer AG Lee s Pharmaceutical Holdings Limited Novartis AG Nyken BV Ono Pharmaceutical Co., Ltd. PhaseBio Pharmaceuticals, Inc. Trevena, Inc. Drug Profiles ANG-4011 BR-5489 cenderitide istaroxime NYK-1112 omecamtiv mecarbil ONO-4232 PB-1046 serelaxin TRV-027 TRV-120023 ularitide For more information visit .researchandmarkets.com/research/jnsg6k/acute_heart